Literature DB >> 22002808

Amyloid-β production: major link between oxidative stress and BACE1.

Elena Tamagno1, Michela Guglielmotto, Debora Monteleone, Massimo Tabaton.   

Abstract

Sequential endoproteolytic cleavages operated by the γ-secretase and the β-secretase (BACE1) on the β-amyloid precursor protein result in the production of the β-amyloid (Aβ) species, with two C-terminal variants, at residue 40 or at residue 42. Accumulation in brain tissue of aggregates of Aβ42 is the major pathogenetic event in Alzheimer's disease (AD). The causes of Aβ accumulation in the common sporadic form of AD are not completely understood, but they are likely to include oxidative stress (OS). Data reviewed here shed light on how Aβ generation, oxidative stress, and secretase functions are intimately related in sporadic AD. According to our hypothesis, in sporadic AD, OS resulted from several cellular insults such as aging, hypoxia, hyperglycemia, and hypercholesterolemia-that are well-known risk factors for AD development-can determine a primary induction of γ-secretase and BACE1. The loop proceeds with the generation of Aβ42 and its signaling to BACE1 transcription.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002808     DOI: 10.1007/s12640-011-9283-6

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  150 in total

1.  Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid.

Authors:  M A Lovell; W R Markesbery
Journal:  Arch Neurol       Date:  2001-03

Review 2.  Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Mark Chao; Akihiko Nunomura; Massimo Tabaton; Robert B Petersen; George Perry; Mark A Smith
Journal:  Antioxid Redox Signal       Date:  2003-10       Impact factor: 8.401

Review 3.  LRP in amyloid-beta production and metabolism.

Authors:  Guojun Bu; Judy Cam; Celina Zerbinatti
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

4.  Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides.

Authors:  Krystyn Z Bourne; Diana C Ferrari; Christine Lange-Dohna; Steffen Rossner; Thomas G Wood; J Regino Perez-Polo
Journal:  J Neurosci Res       Date:  2007-05-01       Impact factor: 4.164

5.  Silent brain infarcts and the risk of dementia and cognitive decline.

Authors:  Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 6.  Alternative routes for the formation of immunochemically distinct advanced glycation end-products in vivo.

Authors:  M Takeuchi; Z Makita
Journal:  Curr Mol Med       Date:  2001-07       Impact factor: 2.222

7.  Pravastatin at 10 mg/day does not decrease plasma levels of either amyloid-beta (Abeta) 40 or Abeta 42 in humans.

Authors:  Kazuhiro Ishii; Takahiko Tokuda; Teruhiko Matsushima; Fuyuki Miya; Shin'ichi Shoji; Shu-ichi Ikeda; Akira Tamaoka
Journal:  Neurosci Lett       Date:  2003-10-30       Impact factor: 3.046

8.  Oxidative stress increases expression and activity of BACE in NT2 neurons.

Authors:  Elena Tamagno; Paola Bardini; Alessandra Obbili; Antonella Vitali; Roberta Borghi; Damiano Zaccheo; Maria A Pronzato; Oliviero Danni; Mark A Smith; George Perry; Massimo Tabaton
Journal:  Neurobiol Dis       Date:  2002-08       Impact factor: 5.996

9.  Analysis of microtubule-associated protein tau glycation in paired helical filaments.

Authors:  M D Ledesma; P Bonay; C Colaço; J Avila
Journal:  J Biol Chem       Date:  1994-08-26       Impact factor: 5.157

10.  The induction of amyloid precursor protein and alpha-synuclein in rat hippocampal astrocytes by diethyldithiocarbamate and copper with or without glutathione.

Authors:  S Y Cheng; L D Trombetta
Journal:  Toxicol Lett       Date:  2004-01-15       Impact factor: 4.372

View more
  30 in total

1.  Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits.

Authors:  Shu-Sheng Jiao; Xiu-Qing Yao; Yu-Hui Liu; Qing-Hua Wang; Fan Zeng; Jian-Jun Lu; Jia Liu; Chi Zhu; Lin-Lin Shen; Cheng-Hui Liu; Ye-Ran Wang; Gui-Hua Zeng; Ankit Parikh; Jia Chen; Chun-Rong Liang; Yang Xiang; Xian-Le Bu; Juan Deng; Jing Li; Juan Xu; Yue-Qin Zeng; Xiang Xu; Hai-Wei Xu; Jin-Hua Zhong; Hua-Dong Zhou; Xin-Fu Zhou; Yan-Jiang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

2.  Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats.

Authors:  Hani S Hafez; Doaa A Ghareeb; Samar R Saleh; Mariam M Abady; Maha A El Demellawy; Hend Hussien; Nihad Abdel-Monem
Journal:  Psychopharmacology (Berl)       Date:  2017-07-22       Impact factor: 4.530

3.  Osthole Protects Bone Marrow-Derived Neural Stem Cells from Oxidative Damage through PI3K/Akt-1 Pathway.

Authors:  Yu-Hui Yan; Shao-Heng Li; Hong-Yan Li; Ying Lin; Jing-Xian Yang
Journal:  Neurochem Res       Date:  2016-10-12       Impact factor: 3.996

4.  Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.

Authors:  Michelle A Erickson; Kim Hansen; William A Banks
Journal:  Brain Behav Immun       Date:  2012-07-15       Impact factor: 7.217

5.  Insulin-associated neuroinflammatory pathways as therapeutic targets for traumatic brain injury.

Authors:  Christian D Cerecedo-López; Jennifer H Kim-Lee; Diana Hernandez; Sandra A Acosta; Cesar V Borlongan
Journal:  Med Hypotheses       Date:  2013-12-01       Impact factor: 1.538

Review 6.  Death by a thousand cuts in Alzheimer's disease: hypoxia--the prodrome.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-02-12       Impact factor: 3.911

Review 7.  One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.

Authors:  Vivek Gupta; Veer B Gupta; Nitin Chitranshi; Sumudu Gangoda; Roshana Vander Wall; Mojdeh Abbasi; Mojtaba Golzan; Yogita Dheer; Tejal Shah; Alberto Avolio; Roger Chung; Ralph Martins; Stuart Graham
Journal:  Cell Mol Life Sci       Date:  2016-06-22       Impact factor: 9.261

Review 8.  Role of oxidative stress in infectious diseases. A review.

Authors:  Miroslav Pohanka
Journal:  Folia Microbiol (Praha)       Date:  2013-03-17       Impact factor: 2.099

9.  Use of medical foods and nutritional approaches in the treatment of Alzheimer's disease.

Authors:  Papan Thaipisuttikul; James E Galvin
Journal:  Clin Pract (Lond)       Date:  2012-03

Review 10.  Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?

Authors:  Xiao-Xin Yan; Chao Ma; Wei-Ping Gai; Huaibin Cai; Xue-Gang Luo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.